JP2025511854A5 - - Google Patents
Info
- Publication number
- JP2025511854A5 JP2025511854A5 JP2024559398A JP2024559398A JP2025511854A5 JP 2025511854 A5 JP2025511854 A5 JP 2025511854A5 JP 2024559398 A JP2024559398 A JP 2024559398A JP 2024559398 A JP2024559398 A JP 2024559398A JP 2025511854 A5 JP2025511854 A5 JP 2025511854A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263329081P | 2022-04-08 | 2022-04-08 | |
| US63/329,081 | 2022-04-08 | ||
| US202263401858P | 2022-08-29 | 2022-08-29 | |
| US63/401,858 | 2022-08-29 | ||
| PCT/US2023/065487 WO2023196941A1 (en) | 2022-04-08 | 2023-04-07 | Treatment of a non-alcoholic fatty liver disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025511854A JP2025511854A (ja) | 2025-04-16 |
| JPWO2023196941A5 JPWO2023196941A5 (https=) | 2026-04-09 |
| JP2025511854A5 true JP2025511854A5 (https=) | 2026-04-09 |
Family
ID=86286479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559398A Pending JP2025511854A (ja) | 2022-04-08 | 2023-04-07 | 非アルコール性脂肪肝疾患の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250283089A1 (https=) |
| EP (1) | EP4504337A1 (https=) |
| JP (1) | JP2025511854A (https=) |
| CN (1) | CN119789859A (https=) |
| CA (1) | CA3247602A1 (https=) |
| WO (1) | WO2023196941A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025074157A1 (en) * | 2023-10-06 | 2025-04-10 | Glaxosmithkline Intellectual Property (No.3) Limited | Treatment of a non-alcoholic fatty liver disease |
| WO2025162271A1 (zh) * | 2024-02-03 | 2025-08-07 | 北京福元医药股份有限公司 | 用于抑制HSD17B13表达的siRNA、其缀合物和药物组合物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102515329B1 (ko) | 2016-03-07 | 2023-03-29 | 애로우헤드 파마슈티컬스 인코포레이티드 | 치료용 화합물을 위한 표적화 리간드 |
| MX2018009853A (es) | 2016-09-02 | 2018-11-09 | Arrowhead Pharmaceuticals Inc | Ligandos de direccion. |
| MX2020001912A (es) * | 2017-09-14 | 2020-03-24 | Arrowhead Pharmaceuticals Inc | Agentes de iarn y composiciones para inhibir la expresion de la angiopoyetina tipo 3 (angptl3) y metodos de uso. |
| MX2021003077A (es) | 2018-09-19 | 2021-05-27 | Arrowhead Pharmaceuticals Inc | Agentes de arni para inhibir la expresion de 17beta-hsd tipo 13 (hsd17b13), composiciones de dichos agentes, y metodos de uso. |
| TW202202153A (zh) * | 2020-03-26 | 2022-01-16 | 美商艾羅海德製藥公司 | 用於抑制ＰＮＰＬＡ３表現之ＲＮＡｉ劑、其醫藥組成物及使用方法 |
-
2023
- 2023-04-07 CN CN202380045597.9A patent/CN119789859A/zh active Pending
- 2023-04-07 JP JP2024559398A patent/JP2025511854A/ja active Pending
- 2023-04-07 CA CA3247602A patent/CA3247602A1/en active Pending
- 2023-04-07 EP EP23721243.6A patent/EP4504337A1/en active Pending
- 2023-04-07 WO PCT/US2023/065487 patent/WO2023196941A1/en not_active Ceased
- 2023-04-07 US US18/854,700 patent/US20250283089A1/en active Pending